Branched Stent Grafts Market Size, Share, and Growth Analysis, By Device Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts), By Material (Nitinol, Polytetrafluoroethylene (PTFE)), By Application, By Region - Industry Forecast 2026-2033

Global Branched Stent Grafts Market size was valued at USD 349.37 Million in 2024 and is poised to grow from USD 376.27 Million in 2025 to USD 681.12 Million by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The global branched stent graft market is experiencing significant growth driven by advancements in medical technology, an increase in endovascular cardiovascular disease repair (EVAR) procedures, and enhanced patient care quality. The rise in the elderly population and the high incidence of aortic and abdominal aneurysms are further fueling market expansion. Additionally, the trend toward minimally invasive surgical techniques presents considerable opportunities for market development. Despite challenges posed by disruptions in healthcare services, such as postponed elective surgeries during global health crises, the overall demand for branched stent grafts continues to rise. This innovative technology expanding the treatment scope for aortic lesions underscores its critical role in modern vascular interventions, positioning it strongly for future growth within the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Branched Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Branched Stent Grafts Market Segments Analysis

Global Branched Stent Grafts Market is segmented by device type, material, application and region. Based on device type, the market is segmented into aortic branched stent grafts, iliac branched stent grafts and femoral branched stent grafts. Based on material, the market is segmented into nitinol, polytetrafluoroethylene (PTFE) and polyester. Based on application, the market is segmented into EVAR, chimney, fenestrated endovascular aortic aneurysm repair and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Branched Stent Grafts Market

The branched stent grafts market is significantly influenced by an increase in endovascular aneurysm repair (EVAR) procedures, enhancements in the quality of patient care, and the ongoing advancements in medical technology. Additionally, the aging population and the rising incidence of abdominal aortic aneurysms (AAA) are contributing to the expansion of this market. These factors collectively create a strong demand for innovative solutions in the treatment of vascular conditions, thereby propelling the growth and development of branched stent grafts within the global medical landscape. As healthcare continues to evolve, the market is poised for further advancements and increased adoption.

Restraints in the Global Branched Stent Grafts Market

The global branched stent grafts market faces notable challenges due to the high costs associated with endovascular aneurysm repair procedures. This financial barrier limits access for individuals from middle and lower-income backgrounds, making it difficult for them to afford the necessary treatments. The significant expenses involved in these procedures serve as a substantial constraint on market growth, as a considerable segment of the population is unable to pursue advanced medical interventions. Consequently, the restrictive pricing dynamics hinder wider adoption and utilization of branched stent grafts in treating vascular ailments, impacting overall market potential.

Market Trends of the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market is witnessing a notable upward trend, driven by the increasing prevalence of vascular diseases and the growing acceptance of minimally invasive surgical techniques. Treatments such as abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR), and thoracic endovascular aneurysm repair (TEVAR) have gained prominence due to their safety, efficacy, and cost-effectiveness, significantly reducing operative times. The integration of advanced imaging guidance technologies, including X-rays, enhances procedural accuracy and outcomes, further propelling market growth. As patient awareness and technological advancements continue to rise, the outlook for branched stent grafts remains robust and promising.